Hedgehog Pathway Blockade Inhibits Melanoma Cell Growth in Vitro and in Vivo

por O’Reilly, Kathryn E., Vega-Saenz de Miera, Eleazar, Segura, Miguel F., Friedman, Erica, Poliseno, Laura, Han, Sung Won, Zhong, Judy, Zavadil, Jiri, Pavlick, Anna, Hernando, Eva, Osman, Iman
Publicado 2013

T cell receptor affinity and avidity defines antitumor response and autoimmunity in T cell immunotherapy

por Krogsgaard, Michelle, Zhong, Shi, Malecek, Karolina, Johnson, Laura A, Yu, Zhiya, Vega-Saenz de Miera, Eleazar, Darvishian, Farbod, McGary-Shipper, Katelyn, Huang, Kevin, Boyer, Joshua, Corse, Emily, Shao, Yongzhao, Rosenberg, Steven A, Restifo, Nicholas P, Osman, Iman
Publicado 2013

The histone demethylase PHF8 regulates TGFβ signaling and promotes melanoma metastasis

por Moubarak, Rana S., de Pablos-Aragoneses, Ana, Ortiz-Barahona, Vanessa, Gong, Yixiao, Gowen, Michael, Dolgalev, Igor, Shadaloey, Sorin A. A., Argibay, Diana, Karz, Alcida, Von Itter, Richard, Vega-Sáenz de Miera, Eleazar Carmelo, Sokolova, Elena, Darvishian, Farbod, Tsirigos, Aristotelis, Osman, Iman, Hernando, Eva
Publicado 2022

Engineering the immune response to "self" for effective cancer immunotherapy

por Zhong, Shi, Malecek, Karolina, Moogk, Duane, Johnson, Laura A, Yu, Zhiya, Grigoryan, Arsen, Vega-Saenz de Miera, Eleazar, Darvishian, Farbod, Gu, Wei Jun, McGary, Katelyn, Huang, Kevin, Boyer, Joshua, Corse, Emily, Yongzhao, Shao, Rosenberg, Steven A, Restifo, Nicholas P, Cardozo, Timothy, Frey, Alan, Osman, Iman, Krogsgaard, Michelle
Publicado 2014

An epigenetic switch controls an alternative NR2F2 isoform that unleashes a metastatic program in melanoma

por Davalos, Veronica, Lovell, Claudia D., Von Itter, Richard, Dolgalev, Igor, Agrawal, Praveen, Baptiste, Gillian, Kahler, David J., Sokolova, Elena, Moran, Sebastian, Piqué, Laia, Vega-Saenz de Miera, Eleazar, Fontanals-Cirera, Barbara, Karz, Alcida, Tsirigos, Aristotelis, Yun, Chi, Darvishian, Farbod, Etchevers, Heather C., Osman, Iman, Esteller, Manel, Schober, Markus, Hernando, Eva
Publicado 2023